Trump seizes on Gates' climate change memo, sparking debate over priorities ahead of COP30.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
S&P Global reports strong Q3 results, raises full-year guidance, and plans strategic divestitures amid market volatility.
Trump seizes on Gates' climate change memo, sparking debate over priorities ahead of COP30.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier $4.9 billion deal and intensifying the race for dominance in the lucrative obesity drug market.
S&P Global reports strong Q3 results, raises full-year guidance, and plans strategic divestitures amid market volatility.